Vadodara: Sun Pharmaceutical Industries Limited’s investee company, Lyndra Therapeutics Inc., has ceased operations due to insufficient funding to continue their business activities.”This is to inform you that the Company has received a communication from our investee company, Lyndra Therapeutics Inc., informing us that they are ceasing operations effective March 26, 2025, due to insufficient funding to continue their business activities,” the Company stated in a BSE filing.In December 2023, the Company invested in Lyndra Therapeutics Inc. This strategic investment was to support the development of innovative pharmaceutical delivery technologies and get access to the technology for certain molecules and territories.The company was incorporated on 14th January, 2015.Sun Pharma is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra. The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies. It includes generics, branded generics, specialty, complex or difficult-to-make technology-intensive products, over-the-counter (OTC), antiretrovirals (ARVs), Active Pharmaceutical Ingredients (APIs), and Intermediates.
Read also: Sun Pharma Laboratories Gets CDSCO Panel Nod To study Esaxerenone Tablets